ReviewJournal of Cancer2017

Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting.

Jennifer Peyling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.